Professor and Vice Chair (Clinical Affairs); Director, MS Comprehensive Care Center Stony Brook University Hospital Stony Brook University Hospital Stony Brook, New York
Multiple sclerosis (MS) has been a leading therapeutic success story in Neurology. Multiple disease modifying therapies (DMTs) have been approved for the major form of MS, relapsing disease. Therapeutic principles have emerged, in particular early DMT use. This talk will cover these principles, new insights into MS therapeutics and future needs.